|
Session 2-4: Peptide and Protein Drug Delivery |
|
|
Day 3: Morning, July. 17, 2021 |
|
|
Chair |
Dr. Joël Richard, Head of Technical and Pharmaceutical Operations, MedinCell, France |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Long Acting Injectables of Fragile Molecules - BEPO Technology: A Game-changing Delivery System Dr. Joël Richard, Head of Technical and Pharmaceutical Operations, MedinCell, France |
|
09:00-09:25 |
Title: TBD Dr. Patrick Y. Lu, Founder, President and CEO, Sirnaomics, USA |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Title: New Peptide Plataforms for Drug Delivery Dr. Paula Margarida Ferreira, Associate Professor, University of Minho, Portugal |
|
10:15-10:30 |
Coffee Break |
|
Session 3-4: New Ocular, Nasal, Pulmonary Delivery |
|
|
Day 3: Morning, July. 17, 2021 |
|
|
Chair |
Dr. Matthias Birkhoff, Vice President , Business Development, AptarPharma, Germany |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Hydroxocobalamin Nasal Spray: Measuring and Modeling of Pharmacokinetics After Repeated Dose Dr. Hubert Pellikaan, Director, NextstepPharma BV, The Netherlands |
|
09:00-09:25 |
Title: Recent Advances in the Delivery of Dry Powder Drug Formulations into the Nasal Cavity Dr. Gerallt Williams, Director Scientific Affairs, Prescription Division, AptarPharma, France |
|
09:25-09:50 |
Title: Topical Ophthalmic Drugs – An Interesting Past and a Fascinating Future Dr. Matthias Birkhoff, Vice President, Business Development, AptarPharma, Germany |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
| 10:30-10:55 |
Speech Opportunity Available |
| 10:55-11:20 |
Speech Opportunity Available |
| 11:20-11:45 |
Title: Comparison of Dissolution Techniques for in Vitro Performance of Dry Powders for Inhalation Dr. Alessandra Rossi, Assistant Professor, Food and Drug Department, University of Parma, Italy |
|
Session 4-3: New Carriers for Drug Delivery |
|
|
Day 3: Morning, July. 17, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: TBD Dr. Ahmed Somaida, Greenwich University, UK |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 5-2: Immunotherapeutics, Gene and Cell Therapy |
|
|
Day 3: Morning, July. 17, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Pathotropic Neural Stem Cells for Selective Delivery of Therapeutic Agents Dr. Karen S. Aboody, Professor, Department of Developmental and Stem Cell Biology, City of Hope National Medical Center & Beckman Research Institute, USA |
|
09:00-09:25 |
Title: Myocardial Infarction Stabilization by Cell-based Expression of Controlled Vascular Endothelial Growth Factor Levels Dr. Ludovic Melly, Deputy Head of Clinic, Cardiac Surgery Service, Université Catholique de Louvain - UCLouvain, Belgium |
|
09:25-09:50 |
Title: TBD Dr. Richard A. Gatti, Distinguished Emeritus Professor, Departments of Pathology & Laboratory Medicine and Human Genetics, David Geffen UCLA School of Medicine, USA |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
Session 2-5: Medical Devices for Drug Delivery, Surgery and Therapy Day 2: Afternoon, July. 16, 2021 Chair Dr. Sandor G. Vari, Director, International Research and Innovation in Medicine Program, Cedars - Sinai Medical Center, Los Angeles, USA Time 13:30-13:35 Chair's Introduction 13:35-13:55 Keynote Speech Title: Minimally Invasive Direct Delivery of Intracerebral Therapeutics in Complex 3D Arrays Dr. Miles Cunningham, Medical Director, McLean Hospital Lincoln Residence; Director, Laboratory for Neural Reconstruction, McLean Hospital, Harvard Medical School, USA 13:55-14:15 Title: Syringe Filling in Isolators with E-Beam Tub Decontamination Dr. Yoann Ferreira, Sales Manager, Skan AG, Switzerland 14:15-14:35 Title: Drug Delivery and Reduced Side Effects of Cancer Drugs with Nanocarriers Dr. Sandor G. Vari, Director, International Research and Innovation in Medicine Program, Cedars - Sinai Medical Center, USA 14:35-14:55 Title: mpSmart: A Low-cost Flow Controlled Micropump System Dr. Frank Bartels, CEO, Bartels Mikrotechnik GmbH, Germany Dr. Lesya Kobylinska, Associate Professor, Danylo Halytsky Lviv National Medical University, Ukraine 15:15-15:30 Coffee Break 15:30-15:50 Title: The Roles of PKC Isoforms (PKCs) in GnRH Stimulation of MAPK Activation in Gonadotrope Cells Dr. Zvi Naor, Professor, Department of Biochemistry and Molecular Biology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel 15:50-16:10 Title:TCI-Anaesthesia-4.0: Next Generation Technologies for a Fully Automated Closed-loop Target-controlled Infusion (TCI) Anaesthesia Dr. Alena Simalatsar, Assistant Professor, HES-SO Valais-Wallis, Switzerland 16:10-16:30 Title:Chemical and Physical Characterization Properties of Molded Glass Dr. Nicola Favaro, Lab Director, StazioneSperimentaleVetro, Italy Title: Innovative Autoinjector Concept for the Application of Complex Biologics Dr. Sigrid Saaler-Reinhardt, Director, Corporate Project Management, Midas Pharma GmbH, Germany 16:50-17:10 Speech Opportunity Available
14:55-15:15
Title: Nano-delivery Approaches with PEG-containing Polymeric Carrier that Enhances Proapoptotic Effects of 4-thiazolidinone-based Chemotherapeutics
16:30-16:50
Abstract and Biography: Submit Here
|
Session 3-5: Targeting Cancer Drug Delivery |
|
|
Day 3: Afternoon, July. 17, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Phospholipid Ether Molecules as a Targeted Drug Delivery Vehicle Specific for Cancer Dr. Jarrod Longcor, Chief Business Officer & SVP Operations, Cellectar Biosciences, USA |
|
09:00-09:25 |
Title: OncoLize: Treating Tumors from the Inside Dr. Mike G.W. De Leeuw, Founder & CEO, OncoLize, the Netherlands |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 4-4: Nanomaterials and Nanocarriers for Drug Delivery |
|
|
Day 3: Afternoon, July. 17, 2021 |
|
|
Chair |
Dr. Steve Faraci, CSO, Cyta Therapeutics, USA |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Volume Nano-encapsulation and Tunable Drug Release from Biodegradable Load Bearing Fe-based Nanocomposites for Orthopedic Implants Dr. Aliya Sharipova, Technion – Israel Institute of Technology, Israel |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Title: Drug-Encapsulated Polymeric Nanogels for the Treatment of Liver Disease Dr. Steve Faraci, CSO, Cyta Therapeutics, USA |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
Session 5-3: Polymer Therapeutics Delivery |
|
|
Day 3: Afternoon, July. 17, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: TBD Dr. Andrzej Dworak, Professor, Centre of Polymer and Carbon Materials, Polish Academy of Sciences, Poland |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
Session 5-4: Computational Methods and Technologies for Optimization of Formulation Development and Drug Delivery |
|
|
Day 3: Afternoon, July. 17, 2021 |
|
|
Chair |
Dr. Urban Fagerholm, PROSILICO AB, Sweden |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Computational Methods Outperforming Labs in Predicting Human Clinical Biopharmaceutics Dr. Urban Fagerholm, PROSILICO AB, Sweden |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
© 2003-2021 All rights reserved by BIT Congress |